|
|
Volumn 22, Issue 2, 2009, Pages 126-128
|
|
Drug repositioning summit: Finding new routes to success
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIASTHMATIC AGENT;
CARDIOVASCULAR AGENT;
DIAZOXIDE;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ETANERCEPT;
FENFLURAMINE;
GASTROINTESTINAL AGENT;
GL 1001;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IMATINIB;
MLR 1023;
PLERIXAFOR;
PREGABALIN;
SILDENAFIL;
TOLIMIDONE;
UNCLASSIFIED DRUG;
VIA 2291;
ALZHEIMER DISEASE;
ANKYLOSING SPONDYLITIS;
ASTHMA;
ATHEROSCLEROSIS;
AUTOIMMUNE DISEASE;
CARDIOMYOPATHY;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST CONTROL;
DEMENTIA;
DIGESTIVE SYSTEM INFLAMMATION;
DRUG DESIGN;
DRUG EFFICACY;
DRUG INDICATION;
DRUG MARKETING;
DRUG SAFETY;
DRUG SCREENING;
DYSLIPIDEMIA;
ERECTILE DYSFUNCTION;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTRIGLYCERIDEMIA;
LYMPHOMA;
MULTIPLE MYELOMA;
NEUROPATHIC PAIN;
NONHUMAN;
OBESITY;
PATENT;
PSORIATIC ARTHRITIS;
RHEUMATOID ARTHRITIS;
STOMACH ULCER;
SYSTEMIC SCLEROSIS;
VALVULAR HEART DISEASE;
CLINICAL TRIALS AS TOPIC;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 65649114787
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: 10.1358/dnp.2009.22.2.1334453 Document Type: Conference Paper |
|
Times cited : (16)
|
|
References (0)
|
